Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Layal El Wazan"'
Autor:
Lyujie Fang, Sandy S.C. Hung, Jennifer Yek, Layal El Wazan, Tu Nguyen, Shahnaz Khan, Shiang Y. Lim, Alex W. Hewitt, Raymond C.B. Wong
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 14, Iss , Pp 184-191 (2019)
Gain-of-function studies often require the tedious cloning of transgene cDNA into vectors for overexpression beyond the physiological expression levels. The rapid development of CRISPR/Cas technology presents promising opportunities to address these
Externí odkaz:
https://doaj.org/article/47be271b713e4be79fe2b7cfc5c1a5da
Autor:
Lyujie Fang, Layal El Wazan, Christine Tan, Tu Nguyen, Sandy S. C. Hung, Alex W. Hewitt, Raymond C. B. Wong
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 13 (2019)
Externí odkaz:
https://doaj.org/article/c172125af033465eb10118db43f979dd
Autor:
Lyujie Fang, Layal El Wazan, Christine Tan, Tu Nguyen, Sandy S. C. Hung, Alex W. Hewitt, Raymond C. B. Wong
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 12 (2018)
Cellular reprogramming technology holds great potential for tissue repair and regeneration to replace cells that are lost due to diseases or injuries. In addition to the landmark discovery of induced pluripotent stem cells, advances in cellular repro
Externí odkaz:
https://doaj.org/article/77922695f3644121ac9803df21047912
Publikováno v:
World Journal of Stem Cells. 11:431-444
Cell therapy offers great promises in replacing the neurons lost due to neurodegenerative diseases or injuries. However, a key challenge is the cellular source for transplantation which is often limited by donor availability. Direct reprogramming pro
Autor:
Shiang Y. Lim, Alex W. Hewitt, Sandy S.C. Hung, Layal El Wazan, Lyujie Fang, Jennifer Yek, Raymond C.B. Wong, Tu Nguyen, Shahnaz Khan
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 14, Iss, Pp 184-191 (2019)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Gain-of-function studies often require the tedious cloning of transgene cDNA into vectors for overexpression beyond the physiological expression levels. The rapid development of CRISPR/Cas technology presents promising opportunities to address these
Publikováno v:
World Journal of Stem Cells
Cell therapy offers great promises in replacing the neurons lost due to neurodegenerative diseases or injuries. However, a key challenge is the cellular source for transplantation which is often limited by donor availability. Direct reprogramming pro